Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, giving promising improvements across a variety of health-related and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA gives a safer, more trusted alternate for therapeutic use, significant